Search

everythinglearnresearchcommunity

for

Search:↓

Surgical hair restoration involves moving hair from a non-balding area to a balding area, with the transplanted hair not subject to male pattern baldness. Medications can slow hair loss and regrow some hair, but successful treatment needs careful planning, skill, and ethical responsibility due to progressive hair loss and limited donor hair.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Most sunscreens meet safety standards, but tanning products often don't.

Use of cosmeceuticals during pregnancy and breastfeeding is not recommended due to insufficient safety data.

The article concludes that products can affect the body without being drugs as long as they don't claim to treat or prevent diseases, except for cosmetic sunscreens.

Taking biotin supplements can be risky and often lacks evidence of effectiveness for skin, hair, and nail issues.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

Newer GLP-1 drugs like semaglutide may cause hair loss.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

JAK inhibitors like baricitinib and ritlecitinib are effective new treatments for severe alopecia areata.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.

Bimatoprost helps with hair growth and eye conditions but can be costly and have side effects.

Some men experience persistent sexual, neurological, and psychological symptoms after stopping finasteride, but evidence of permanent damage is inconclusive.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Platelet Rich Plasma (PRP) is increasingly used in cosmetic dermatology for hair loss, facial rejuvenation, and after cosmetic procedures, and can be stored for up to 90 days for daily home use.

The conclusion is that finasteride is linked to an increased risk of suicidal thoughts and a higher risk of completed suicide when used for hair loss.

Lasers are FDA-approved for permanent hair reduction, not removal, and more research is needed to improve treatments.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

Finasteride may reduce prostate tumor cell invasion and spread.

Synthetic hairs have side effects and need careful use.

Minoxidil is strongly linked to heart problems, and machine learning can improve drug safety checks.

Oral finasteride may cause more sexual side effects than expected, possibly due to negative publicity and reporting bias.

Low-dose oral minoxidil may be a promising alternative to topical minoxidil for hair loss.

Effective alopecia treatments exist, but high costs and limited access remain challenges.

Finasteride, dutasteride, and silodosin have the highest risk for causing sexual dysfunction.

Minoxidil can temporarily increase hair shedding, causing anxiety and treatment discontinuation.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

New treatments are needed for non-scarring alopecia due to current limitations.